Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS +47.45%·Rev n/aQ3 24EPS +18.07%·Rev n/aQ2 24EPS -33.68%·Rev n/aQ1 24EPS -9.09%·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Ellen Cavaleri — Investor Relations or Corporate Communications

Matthew Klein — Chief Executive Officer

Eric Pauwels — Chief Business Officer

Pierre Gravier — Chief Financial Officer

+9.3%1d on move date+7.7% vs SPY3d+2.4%5d+4.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access